News

BioM's articles and press releases about the Bavarian biotechnology sector


Record financing in Martinsried: CatalYm secures 150 million US dollars for breakthrough in cancer treatment

CatalYm has closed a USD 150 mil­lion Ser­ies D fin­an­cing round to ad­vance the fur­ther de­vel­op­ment of its Visu­gromab an­ti­body. The…

SciRhom secures EUR 63 million in Series A financing round for antibody therapy against autoimmune diseases

Martin­sried-based start-up SciRhom has raised €63 mil­lion in a Ser­ies A fin­an­cing round to ad­vance its iRhom2-tar­geted an­ti­body…

Electrochaea GmbH is strategic Partner in Canadian 3rd generation renewable natural gas production

Elec­tro­chaea GmbH from Planegg/München will be in­volved in feas­ib­il­ity study of a pro­ject aimed at pro­du­cing 3rd gen­er­a­tion…

Bavaria shows the great potential of AI and data in medicine: High potential for Germany's health

Bi­o­tech­no­logy con­fer­ence "BayOCon­nect" in Mu­nich unites play­ers from all areas of Bav­ari­an and in­ter­na­tion­al…

Apply for the 8th batch of the 4C Accelerator by July 19!

You have an in­nov­at­ive product idea in the MedTech sec­tor? You want to de­vel­op a prom­ising busi­ness model and learn how to…

BioM publishes report „Biotech in Bavaria 2023/24“: Bavarian biotechnology grows and achieves record financing

Auf der dies­jährigen BayOCon­nect-Kon­fer­enz präsen­tierte BioM den ak­tuel­len Jahresre­port "Bi­otech in Bav­aria 2023/24 –…

MAxL in Martinsried: Bio M opens new start-up incubator - 8.5 million euros for innovative start-up teams to strengthen biotechnology in Bavaria

BioM Bi­otech Cluster Devel­op­ment GmbH to­geth­er with State Sec­ret­ary To­bi­as Got­thardt has of­fi­cially opened the start-up…

BioFIT 2024 - get the BioM discount

We offer our net­work 20% dis­count for BioFIT 2023 - Decem­ber 3rd and 4th, 2024 | In-per­son, Lille (France) and Decem­ber 11th & 12th,…

BARDA VITAL Prize (BVP) Challenge: BARDA VITAL Global Health Security Symposium in Berlin

VITAL is on the hunt for break­through vac­cines and thera­peut­ics plat­forms and en­abling tech­no­lo­gies, and it is call­ing on bi­otech…

Eisbach Bio announces FDA clearance of IND application for EIS-12656, a first-in-class allosteric inhibitor of ALC1

Eis­bach Bio GmbH, a privately-held clin­ic­al-stage bi­o­tech­no­logy com­pany in Martin­sried pi­on­eer­ing can­cer medi­cines lever­aging…

Newsletter

Subscribe

Archive


12.07.2023

Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), LMU Klinikum Großhadern

Zukun­ft der Med­iz­in: Helm­holtz Mu­nich er­öffnet In­nov­a­tion­scam­pus

11.07.2023

Friedrich-Alexander-Universität Erlangen-Nürnberg

Fein­tun­ing für Antikörp­er

11.07.2023

GDCH Gesellsch. Deutscher Chemiker Nachrichten aus Chemie, Technik u. Laboratorium

Stat­istik der Chemi­estud­i­engänge: Weni­ger An­fänger, mehr Ab­schlüsse

10.07.2023

Bayerisches Staatsministerium für Gesundheit und Pflege

Stark-Watzinger: Wir brin­g­en das Wis­sen aus der Forschung schneller in die An­wendung


Publish press release

 To the login


Gabriele Klingner
Gabriele Klingner

Communications & Marketing Lead


Christiane Proll
Christiane Proll

PR & Social Media Manager